Simplex Trading’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-50
Closed -$3K 7274
2017
Q3
$3K Buy
50
+10
+25% +$110 ﹤0.01% 4963
2017
Q2
$2K Buy
40
+20
+100% +$200 ﹤0.01% 5460
2017
Q1
$2K Sell
20
-210
-91% -$2.1K ﹤0.01% 5472
2016
Q4
$2K Buy
+230
New +$2.3K ﹤0.01% 5239
2016
Q3
Sell
-20
Closed -$3K 6933
2016
Q2
$3K Buy
+20
New +$262 ﹤0.01% 4795
2016
Q1
Sell
-68
Closed -$2K 6767
2015
Q4
$2K Buy
68
+5
+8% +$42 ﹤0.01% 4700
2015
Q3
$1K Buy
+63
New +$540 ﹤0.01% 5317
2015
Q2
Sell
-10
Closed -$1K 6271
2015
Q1
$1K Buy
10
+2
+25% +$16 ﹤0.01% 4756
2014
Q4
$1K Buy
+8
New +$65 ﹤0.01% 4461

Simplex Trading's SCLN Position: Q4 2017 in Review

Simplex Trading sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 23 shares.

Simplex Trading first reported a position in SCLN in Q4 2014 and held it in 8 quarters. The position peaked at $56K in Q1 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Simplex Trading reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Simplex Trading sold 23 Sciclone Pharmaceuticals Inc shares in Q4 2017.
  • Simplex Trading first reported a position in Sciclone Pharmaceuticals Inc in Q4 2014 and held it in 8 quarters.
  • Simplex Trading's Sciclone Pharmaceuticals Inc position peaked at $56K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Simplex Trading's 13F filing for Q4 2017, filed 10 Jan 2018.